๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Recurrent Endometrial Carcinoma

A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies NCT05803018Phase 1, Phase 21 site๐Ÿ“ Shanghai Sichuan Baili Pharmaceutical Co., Ltd. ยท Tests: BL-B01D1 Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers NCT03564340Phase 1, Phase 254 sites๐Ÿ“ Birmingham๐Ÿ“ Boston๐Ÿ“ Boston Regeneron Pharmaceuticals ยท Tests: Ubamatamab, Cemiplimab, Sarilumab, Tocilizumab A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Chinese Participants With Primary Advanced or Recurrent Endometrial Cancer (EC) NCT07108270Phase 21 site๐Ÿ“ Jinan GlaxoSmithKline ยท Tests: Dostarlimab, Carboplatin, Paclitaxel Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma NCT05603910Phase 11 site๐Ÿ“ Miami Aaron Wolfson ยท Tests: Lenvatinib, Pembrolizumab, Hypofractionated External Beam Radiation Therapy, High-Dose Rate (HDR) Brachytherapy A Study of BL-B01D1 + Pembrolizumab ยฑ Bevacizumab in Patients With Recurrent or Metastatic Cervical Cancer and Endometrial Cancer NCT07054567Phase 21 site๐Ÿ“ Shanghai Sichuan Baili Pharmaceutical Co., Ltd. ยท Tests: BL-B01D1, Pembrolizumab, Bevacizumab A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Whittier Daiichi Sankyo ยท Tests: Ifinatamab deruxtecan Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer NCT06040970Phase 1, Phase 21 site๐Ÿ“ New York Icahn School of Medicine at Mount Sinai ยท Tests: Sacituzumab, Cisplatin Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-ฮฑ Positive Endometrial Cancer NCT03832361Phase 21 site๐Ÿ“ New Haven Alessandro Santin ยท Tests: IMGN853 Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers NCT05049538n/a1 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Biospecimen Collection, Liquid Biopsy, Pap Smear Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer NCT06463028Phase 218 sites๐Ÿ“ La Jolla๐Ÿ“ San Francisco๐Ÿ“ Miami Beach Faeth Therapeutics ยท Tests: Sapanisertib, Serabelisib, Paclitaxel The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study. NCT04403867n/a1 site๐Ÿ“ Milan Fondazione IRCCS Istituto Nazionale dei Tumori, Milano ยท Tests: Sentinel lymph node (SLN) biosy +/- lymphadenectomy Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer NCT07198074Phase 3304 sites๐Ÿ“ Birmingham๐Ÿ“ Anchorage๐Ÿ“ Phoenix National Cancer Institute (NCI) ยท Tests: Bevacizumab, Biospecimen Collection, Carboplatin, Computed Tomography, Magnetic Resonance Imaging Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma NCT05112601Phase 2138 sites๐Ÿ“ Birmingham๐Ÿ“ Athens๐Ÿ“ Augusta National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Computed Tomography, Ipilimumab, Magnetic Resonance Imaging, Nivolumab Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma NCT06532539Phase 21 site๐Ÿ“ Jinan Shandong Cancer Hospital and Institute ยท Tests: Paclitaxel and Cisplatin, Cadonilimab, Radiotherapy Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform NCT06349642n/a3 sites๐Ÿ“ Phoenix๐Ÿ“ Jacksonville๐Ÿ“ Rochester Mayo Clinic ยท Tests: Biospecimen Collection, Tissue Collection Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic NCT07807345Phase 16 sites๐Ÿ“ Orlando๐Ÿ“ Boston๐Ÿ“ Oklahoma City Sutro Biopharma, Inc. ยท Tests: STRO-006, Pembrolizumab CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors NCT05410717Phase 11 site๐Ÿ“ Guangzhou Second Affiliated Hospital of Guangzhou Medical University ยท Tests: Claudin6, GPC3, Mesothelin, or AXL targeting CAR-NK cells Uterine Manipulator Versus no Uterine Manipulator in Endometrial Cancer Trial NCT05687084NA3 sites๐Ÿ“ Cuneo๐Ÿ“ Reggio Emilia๐Ÿ“ Verona Universita di Verona ยท Tests: Uterine manipulator use PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer NCT03621904n/a1 site๐Ÿ“ Nijmegen Radboud University Medical Center ยท Tests: Hormonal Antineoplastics Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma NCT05559879Phase 1, Phase 21 site๐Ÿ“ Birmingham University of Alabama at Birmingham ยท Tests: Cabo + Dostarlimab NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometrial Cancer (DUOLife) NCT06890273n/a49 sites๐Ÿ“ Amberg๐Ÿ“ Bad Nauheim๐Ÿ“ Bautzen AstraZeneca A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study) NCT06023862Phase 227 sites๐Ÿ“ Clayton๐Ÿ“ Waratah๐Ÿ“ Melbourne Yonsei University ยท Tests: Dostarlimab, Bevacizumab, Doxorubicin, Gemcitabine, Paclitaxel Study of EV for Recurrent Endometrial Carcinoma NCT07139977Phase 21 site๐Ÿ“ Milwaukee William Bradley ยท Tests: Enfortumab Vedotin A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors NCT06515613Phase 115 sites๐Ÿ“ Little Rock๐Ÿ“ Beverly Hills๐Ÿ“ Denver Context Therapeutics Inc. ยท Tests: CTIM-76 Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial NCT05564377Phase 2484 sites๐Ÿ“ Birmingham๐Ÿ“ Mobile๐Ÿ“ Anchorage National Cancer Institute (NCI) ยท Tests: Alpelisib, Binimetinib, Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer NCT06989112Phase 3257 sites๐Ÿ“ Tucson๐Ÿ“ Little Rock๐Ÿ“ Duarte AstraZeneca ยท Tests: Trastuzumab deruxtecan, Rilvegostomig, Pembrolizumab, Carboplatin, Paclitaxel A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors NCT05150691Phase 1, Phase 2102 sites๐Ÿ“ Cerritos๐Ÿ“ Los Angeles๐Ÿ“ San Diego DualityBio Inc. ยท Tests: DB-1303/BNT323, Pertuzumab Injection, Ritonavir, Itraconazole ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer NCT07270666NA7 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: ctDNA Testing, Blood draw, Surveys, Semi-structured interviews Laparoscopic Robot-assisted Pelvic Exenteration for Pelvic Primary and Recurrent Cancers NCT05186493NA1 site๐Ÿ“ Oslo Oslo University Hospital ยท Tests: robot-assisted total pelvic exenteration Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer NCT05797831Phase 2, Phase 383 sites๐Ÿ“ Vallejo๐Ÿ“ Atlanta๐Ÿ“ Savannah Kartos Therapeutics, Inc. ยท Tests: Navtemadlin, Navtemadlin Placebo
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy